Skip to main content
. Author manuscript; available in PMC: 2020 Apr 15.
Published in final edited form as: Clin Cancer Res. 2019 Jul 23;25(20):6160–6169. doi: 10.1158/1078-0432.CCR-18-3603

Table 3a.

Multivariable model for PFS and OS of significant clinical variables in univariate analysis

PFS OS

HR (95% CI) p-value HR (95% CI) p-value

ECOG PS
≥2 vs. 0–1 1.67 (1.1–2.5) 0.004 2.08 (1.37–3.16) 0.001

No. of metastatic sites
≥3 vs. <3 1.7 (1.2–2.3) 0.004 2.36 (1.62–3.45) <0.001

No. of prior therapies
≥3 vs. <3 1.57 (1.1–2.3) 0.014 1.73 (1.16–2.6) 0.008

Type of ICI therapy
Combination vs. single-agent NA NA 0.7 (0.5–1.07) 0.096